Optical Microcavity Bioparticle Analysis via Cavity Ring-Down Spectroscopy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing bioMEMS technologies are limited in analyzing bioparticles of varying sizes, particularly small ones, and fail to relate measured optical properties to biomolecular composition, making it difficult to differentiate between normal and diseased cells, especially at early disease stages.
Innovation Solution
The use of microfluidic biosensors, optical resonators, and nanolasers to measure optical properties of bioparticles, enabling the analysis of bioparticles across a wide size range, relating refractive index to biomolecular composition, and providing methods for calibrating and maintaining measurement fidelity, allowing for rapid differentiation between healthy and diseased states.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional optical analysis methods are used, then analysis speed is improved, but measurement precision for small bioparticles deteriorates
Solution Approach 1:
The patent changes the optical parameters by using cavity ring-down spectroscopy instead of traditional absorption spectroscopy. This involves measuring the decay rate of light in an optical cavity rather than direct absorption, which dramatically increases sensitivity for small bioparticles while maintaining fast analysis speeds. The parameter change from direct absorption measurement to ring-down time measurement resolves the contradiction between speed and precision for small particles.
2Difficulty of detecting and measuring
If fluorescent probes are used, then detection capability is improved, but device complexity and preparation time worsen
Solution Approach 1:
The patent extracts and eliminates the need for fluorescent probes by using intrinsic optical properties of bioparticles measured through cavity ring-down spectroscopy. This removes the complexity of probe preparation, labeling, and associated equipment while maintaining or improving detection capability through the highly sensitive ring-down measurement technique.
Solution Approach 2:
The method uses the intrinsic optical absorption properties of bioparticles themselves as the detection mechanism, without requiring external fluorescent labels. The bioparticles serve their own detection function through their natural interaction with light in the optical cavity, eliminating the need for separate probing systems and reducing overall device complexity.
3Ease of operation
If geometric optical regime (a>>λ) is used, then analysis simplicity is improved, but adaptability to different bioparticle sizes deteriorates
Solution Approach 1:
The patent changes the fundamental measurement parameter from geometric optics approximations to cavity ring-down time, which is sensitive to absorption across all particle size regimes. This parameter change allows the same simple measurement approach to work for particles from much smaller than wavelength to much larger than wavelength, resolving the contradiction between simplicity and adaptability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid and accurate analysis of bioparticles, facilitating early disease detection and improving cancer diagnosis by correlating optical properties with biomolecular changes, reducing the need for fluorescent probes and enabling high-speed analysis of small bioparticles.
Implementation Method 1
The invention uses technology of BioMEMs, biosensors, microcavity optical resonators, and nanolaser devices to enable powerful new tools for the rapid, accurate analysis of optical properties of cells, organelles, and other bioparticles.
Implementation Method 2
analysis methods and apparatus used as a microfluidic biosensor, optical resonator, and micro- and nanolaser device that measure optical properties of bioparticles
Data Source
AI summary
This invention provides new methods and apparatus for rapidly analyzing a single bioparticle or a plurality of bioparticles to assess their condition. The invention is enabled by an optical microcavity comprising reflective structures to confine light and bioparticles in the same space. Under resonance conditions, an electromagnetic standing wave is established in the microcavity to interact with the bioparticle. Means are provided to bring a bioparticle into the microcavity and to detect changes in the resonance condition with and without the bioparticle in the microcavity. Information about the bioparticle is obtained using the benefits of light interactions as fast, non-contacting, and non-destructive.